Development of a CTL Epitope-Based Vaccine Targeting Tumor Antigens in Esophageal Cancer: An Immunoinformatic Study.
The vaccine demonstrates strong potential as a safe, stable, and broadly applicable immunotherapeutic candidate against esophageal cancer, pending experimental validation.
Authors
- Hongyou Cao (ORCID: https://orcid.org/0000-0003-4891-1973)
- Fengjiao Ding (ORCID: https://orcid.org/0009-0006-3285-1047)
Institutions
- Ankang City Central Hospital (CN)
Publication Details
- Journal
- PubMed
- Published
- 2025-10-01
- DOI
- https://doi.org/10.30498/ijb.2025.509383.4084
- Primary Topic
- vaccines and immunoinformatics approaches
- Type
- article
- Field-Weighted Citation Impact
- 0.00